Wall Street Zen upgraded shares of Cardlytics (NASDAQ:CDLX – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning.
A number of other equities research analysts also recently issued reports on CDLX. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Thursday, June 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Finally, Lake Street Capital set a $10.00 target price on shares of Cardlytics in a report on Friday, May 8th. One research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Sell” and a consensus price target of $10.00.
View Our Latest Report on CDLX
Cardlytics Trading Up 4.1%
Cardlytics (NASDAQ:CDLX – Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported ($1.50) EPS for the quarter, beating analysts’ consensus estimates of ($2.30) by $0.80. Cardlytics had a negative net margin of 55.92% and a negative return on equity of 956.56%. The company had revenue of $36.88 million for the quarter, compared to analysts’ expectations of $37.00 million. As a group, equities research analysts predict that Cardlytics will post -1.1 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO David Thomas Evans bought 15,000 shares of the company’s stock in a transaction on Friday, May 15th. The stock was bought at an average cost of $6.50 per share, with a total value of $97,500.00. Following the transaction, the chief financial officer directly owned 26,793 shares in the company, valued at $174,154.50. The trade was a 127.19% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Amit Gupta sold 9,640 shares of the business’s stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60. Following the sale, the chief executive officer owned 113,850 shares in the company, valued at $499,801.50. This trade represents a 7.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 18,289 shares of company stock worth $80,289. 5.90% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Cardlytics
Several large investors have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new stake in Cardlytics during the 4th quarter worth approximately $39,000. Qube Research & Technologies Ltd purchased a new position in Cardlytics in the 3rd quarter valued at approximately $55,000. Marshall Wace LLP acquired a new position in shares of Cardlytics in the second quarter worth $59,000. Renaissance Technologies LLC acquired a new position in shares of Cardlytics in the fourth quarter worth $62,000. Finally, Barclays PLC increased its position in shares of Cardlytics by 31,167.6% during the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock worth $64,000 after acquiring an additional 55,790 shares during the period. 68.10% of the stock is owned by hedge funds and other institutional investors.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
- Five stocks we like better than Cardlytics
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
